IFNG and invasive carcinoma: The observed minimium for IFNγ release in CIN III but not in invasivecarcinoma differs from the observations of an earlier study by Mori et al.[18] where PHA-stimulated IFNγrelease from PBMCs in cases of invasive carcinoma was significantly decreasedwhen compared with data from healthy women.